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Abstract: Adequate vegetable consumption is one of the cornerstones of a healthy diet. The
recommendation to increase vegetable intake is part of most dietary guidelines. Despite widespread
and long-running public health messages to increase vegetable intake, similar to other countries
worldwide, less than 1 in 10 adult Australians manage to meet target advice. Dietary guidelines
are predominantly based on studies linking diets high in vegetables with lower risk of chronic
diseases. Identifying vegetables with the strongest health benefits and incorporating these into
dietary recommendations may enhance public health initiatives around vegetable intake. These
enhanced public health initiatives would be targeted at reducing the risk of chronic diseases, such as
cardiovascular diseases (CVD). Specific vegetable types contain high levels of particular nutrients
and phytochemicals linked with cardiovascular health benefits. However, it is not clear if increasing
intake of these specific vegetable types will result in larger benefits on risk of chronic diseases. This
review presents an overview of the evidence for the relationships of specific types of vegetables,
including leafy green, cruciferous, allium, yellow-orange-red and legumes, with subclinical and
clinical CVD outcomes in observational epidemiological studies.
Keywords: vegetables; leafy green; cruciferous; allium; yellow-orange-red; legumes; carotenoids;
organosulfur compounds; nitrate; cardiovascular diseases
1. Introduction
Poor diet is a major contributor to the risk of chronic diseases. Chronic diseases, including
cardiovascular diseases (CVD), cancer, chronic respiratory diseases and diabetes, account for 90% of
all deaths in Australia [1] and 70% of all deaths worldwide [2]. Of these, CVD remains the number
one cause of death [2–4]. There is abundant evidence supporting public health practice promoting
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increases in vegetable intake [5–7], which is the cornerstone of dietary approaches for chronic disease
primary prevention. Despite widespread and long-running health promotion messages to increase
vegetable intake [8], the majority of the world’s population have low vegetable intakes [9–11].
Current dietary guidelines promote an increase in intake of all vegetables [5–7]. These guidelines
are mainly based on epidemiological evidence linking diets high in vegetables with lower incidence of
chronic disease [12], and are supported by data suggesting that individual nutrients found abundantly
in vegetables are protective [13–15]. Some vegetables may have substantially larger health benefits in
comparison to others, implying not all vegetables are the same [16,17]. Therefore, the improvement of
dietary guidelines to include targeted advice on consuming specific types of vegetables may enhance
population health approaches to increase vegetable intake.
This narrative review focuses on the cardiovascular health benefits of specific vegetable types
in observational epidemiological studies. Vegetables can be classified according to their chemical
constituents or by biological classifications based on similarities such as evolutionary relationships.
Frequently, these classification systems categorize similar vegetables together. Types of vegetables
discussed in this review include leafy green, cruciferous, allium, yellow-orange-red and legumes.
2. Nutrients and Phytochemicals in Vegetables
Vegetables contain many nutrients and phytochemicals that have been proposed to have
cardiovascular health benefits [18]. Phytochemicals are compounds found in plant-based foods
that have previously been considered non-essential components of the diet [19]. However, emerging
evidence suggests phytochemicals extend benefits beyond that of basic nutrients and may be a vital
part of a healthy diet [18]. Phytochemicals are produced by plants to reduce the risks of environmental
stresses, such as insect attacks; however, when consumed by humans, they may exhibit a wide range of
health benefits [19]. While over 20,000 phytochemicals have been identified in plant foods [20], a large
percentage remain unknown or are poorly understood [21]. Many of these phytochemicals have been
isolated to build an understanding of the benefits towards human health [18,22]. For the classification
of phytochemicals, see Figure 1.
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Meta-anal ses have shown nutrie ts, such as dietary fiber [13 magnes um [15] and
potassium [14], nd phytochemicals, such as flavonoids [23] and carotenoids [24–27], are associated
with benefits on cardiovascular health. Evidence also suggests cardiovasc lar health benefits of other
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nutrients, such as vitamin K [28] and vitamin C [29], and phytochemicals, such as nitrate [30,31]
and organosulfur compounds [32]. These nutrients and phytochemicals may protect against CVD
by a number of mechanisms. These include modulating enzyme activity; altering gene expression
and signaling pathways; regulation of blood pressure; regulation of lipid and glucose metabolism;
influence on antioxidant, anti-inflammatory, and antiplatelet activity; effects on endothelial function;
and attenuation of myocardial damage [33]. In particular, carotenoids which are phytochemicals found
abundantly in yellow-orange-red and dark green leafy vegetables [34], have been postulated to reduce
oxidative stress and inflammation. This may be achieved by influencing transcription factors, such as
nuclear factor κB (NFκB) or nuclear factor erythroid 2-related factor 2 (Nrf2), and their downstream
targets, such as interleukin 8 (IL-8) and prostaglandin E2 (PGE2) or heme oxygenase (Hmox-1) and
superoxide dismutase (SOD), respectively [35].
Strong evidence suggests nitrate, found abundantly in leafy green vegetables, beetroot and
radish [36], can increase nitric oxide (NO) via the enterosalivary nitrate-nitrite-NO pathway. Nitric
oxide is a cell signaling molecule important for vascular homeostasis [37]. Nitric oxide is involved
in many physiological and pathological processes such as relaxing vascular smooth muscle tissue,
increasing regional blood flow, and inhibiting platelet and leukocyte adhesion to vessel walls [38].
A combination of all these physiological benefits are likely to slow the progression of atherosclerosis.
Evidence suggests organosulfur compounds may also slow the progression of atherosclerosis through
anti-inflammatory and antiplatelet effects [39,40].
Organosulfur compounds are organic sulfur-containing compounds often associated with their
foul odours. Glucosinolates, a class of organosulfur compounds, are found almost exclusively in
cruciferous vegetables such as cabbage, broccoli, kale and Brussels sprouts. Anti-inflammatory
properties of isothiocyanates, a breakdown product of glucosinolates, have been proposed through
activation of the redox-sensitive transcription factor Nrf2, which control the expression of antioxidant
and phase II enzymes [39]. Furthermore, studies have demonstrated in vitro inhibition of platelet
aggregation of thiosulfinates, a class of organosulfur compounds found in allium vegetables such as
garlic, onions, shallots, leeks and chives [40].
3. Classification of Vegetables
Large observational epidemiological studies have classified vegetable types in different ways.
This is usually related to countries having varied accessibility and availability of different vegetable
types [41]. Some large epidemiological studies have investigated individual vegetables, whilst others
have investigated vegetable types grouped together based on botanical families, colors, or plant
parts (e.g., stems and stalks, and leaves) [12,41]. The botanical classification of vegetables is based
on physiological characteristics and include vegetables grouped under their botanic family name.
Examples include Amaryllidaceae (garlic, leek, onion, and scallion), Chenopodiacea (beet and beet
greens, spinach, and Swiss chard), Cruciferae/Brassica (broccoli, Brussels sprouts, cauliflower, Chinese
broccoli, Chinese cabbage, collards, and kale) and Leguminosae (green peas, kidney beans, lentils,
green snap beans, snowpeas, and soybeans) [41]. Color classification reflects the pigments of vegetable
plant tissues and can also reflect the presence of phytochemicals such as beta-carotene (deep orange),
anthocyanidin (red) and chlorophyll (green) [41]. Plant part classification is based on the edible part of
the vegetable, including stems and stalks, leaves, legumes, bulbs, and roots and tubers. Stem and stalk
vegetables, such as celery, are predominately high in dietary fiber due to their supported structure [41].
Leaves of vegetables are the most metabolically active and tend to be the most nutritious part of the
vegetable being a good source of folate, carotenoids, vitamin C, flavonols, iron, zinc, calcium and
magnesium [41]. Legumes are a good source of protein, starch, isoflavones, vitamin B6, folate and
iron [41]. Bulbs are a good source of organosulfur compounds, in particular allicin [41]. Roots and
tubers, such as potatoes, are a good source of resistant starch which may help maintain a healthy
gut [42]. Gut dysbiosis has been shown to be associated with intestinal inflammation and has been
linked to the development of CVD [43].
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It has been suggested that grouping vegetables based on food components of public health
significance is a way for nutrition professionals to explore health benefits [41]. Groupings often
include dark green leafy vegetables; cabbage family vegetables; lettuces; allium family bulbs;
legumes; deep orange/yellow roots and tubers; and tomatoes and other red vegetables. Despite
the comprehensiveness in the development of this grouping system, there are some limitations. One
limitation is that vegetable components, such as nitrate and organosulfur compounds, are not taken
into consideration. In addition, observational cohort studies are restricted to specific groupings due to
limited vegetable items on food frequency questionnaires.
The following sections discuss the associations of specific vegetables types, including leafy
green, cruciferous, allium, yellow-orange-red and legumes, with subclinical and clinical CVD
outcomes. The aforementioned vegetable types are based on the above groupings of vegetables
as well as dietary guidelines around the world, and have been modified slightly to align with
specific phytochemicals found abundantly in these vegetable types. These include nitrate (leafy green
vegetables) [44,45]; organosulfur compounds such as glucosinolates (cruciferous vegetables) [46,47]
and cysteine sulfoxides (allium vegetables) [32]; carotenoids such as lycopene and bete-carotene
(yellow-orange-red vegetables) [24–26,48]; and polyphenolic compounds such as isoflavones and
saponins (legumes) [49]. For more information on other nutrients and phytochemicals associated with
these vegetable types, see Figure 2.
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4. Subclinical Measures of Atherosclerosis
Atherosclerosis, the underlying cause of CVD, is a complex multifactorial disorder of the
arteries initiated by endothelial dysfunction, inflammation and dyslipidemia [56,57]. Carotid artery
intima-media thickness (IMT) and focal plaques are subclinical measures of atherosclerosis, both of
which have been shown to predict CVD outcomes [58–60]. Although carotid artery IMT and focal
plaques are both interrelated, they may reflect different biological aspects of atherogenesis [61]. Carotid
artery IMT captures both the atherosclerotic process as well as the compensatory thickening of the
carotid wall in response to ageing and hypertension [62], and is strongly related to ischemic stroke [61].
Carotid focal plaques capture the atherosclerotic process, are dependent on the influx of lipids into the
plaque, and are more related to hyperlipidemia and myocardial infarction [61].
Diets rich in vegetables, such as the vegetarian diet and the Mediterranean diet, have been shown
to be associated with lower carotid artery IMT [63,64] and delayed progression of atherosclerotic
plaques [65]. Very few observational cohort studies have investigated the relationships of vegetable
intake alone and/or specific vegetable types with subclinical measures of atherosclerosis [66]. To our
knowledge, we are the first to publish an association of total vegetable intake, and in particular,
intake of cruciferous vegetables, with carotid artery IMT [67]. However, no relationship between total
vegetable intake and carotid atherosclerotic plaque was observed. This could be due to carotid artery
IMT and carotid focal plaques differing in biological aspects of atherogenesis as described above.
5. Cardiovascular Disease Clinical Endpoints
Increasing vegetable intake is widely recommended for reducing CVD risk, along with other
chronic disease. These recommendations are incorporated into dietary guidelines around the
world [5–7] and are primarily based on large-scale prospective cohort studies linking diets high
in vegetables with lower chronic disease risk. The amount of vegetable intake recommended in
dietary guidelines vary globally, but is usually around 5–6 servings/day (375–450 g/day). More than
60 prospective cohort studies have been undertaken to investigate the associations of total vegetable
intake and/or intake of specific vegetables with CVD endpoints [12]. In a recent meta-analysis,
Aune et al. [12] showed a summary relative risk (RR) of 0.90 (95%CI 0.87, 0.93) for CVD per 200 g/day
increase of vegetable intake. Evidence suggested this relationship was nonlinear (Pnonlinearity = 0.04)
with steeper inverse associations at lower levels of intake. However, the relationship “appeared”
approximately linear with the greatest CVD benefits observed at intakes of 600 g/day, which is
slightly higher than most dietary guideline recommendations. For vegetable types, leafy green
vegetables, cruciferous vegetables, and tomatoes were inversely associated with CVD risk in nonlinear
dose-response analyses. The greatest CVD benefits were observed at intakes of ≥200 g/day for
cruciferous vegetable, ≥120 g/day for leafy green vegetables, and ≥200 g/day for tomatoes [12].
However, only a few studies were included in these analyses, therefore results need to be interpreted
with caution.
5.1. Leafy Green Vegetables
At least 14 studies have reported the associations between intake of leafy green vegetables and
CVD [68–71], atherosclerotic vascular disease (ASVD) [72], coronary heart disease (CHD) [73–75], heart
disease [76] or stroke [76–79] (Table 1). The most common vegetables included in the classification
of leafy green vegetables were spinach and lettuce. Most studies have demonstrated significant
inverse associations between intakes of leafy green vegetables and CVD outcomes [68,71,73,74,76,78].
However, other studies have demonstrated no association [69,70,72,75–77,79]. Most positive studies
have been conducted in US cohorts [68,71,73,78], with the exception of one in Italy [74] and another
in China [76]. Studies demonstrating no associations were conducted in cohorts from Spain [70],
Denmark [79], Sweden [77], the Netherlands [75], Japan [69], China [76] and Australia [72].
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Table 1. Prospective cohort studies of leafy green vegetables and cardiovascular disease outcomes.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
NHS and HPFS (USA) 109,635 M and F 30–75 FFQ CVD (fatal or nonfatal MI or stroke) 12–15 11% ↓ RR (perserving/day) Hung, 2004 [68]
JPHCPS (Japan) 77,891 M and F 45–74 FFQ CVD (fatal or nonfatal MI or stroke) 5–8 No association Takachi, 2007 [69]
PREDIMED (Spain) 7216 M and F 55–80 FFQ CVD (cardiovascular death, MI or stroke) 7 No association Buil-Cosiales, 2016 [70]
MHCPS (USA) 1273 M and F ≥66 FFQ CVD (death) 4.75 51% ↓ RR (≥1 vs.<1 serving/day) Gaziano, 1995 [71]
PLSAW (Australia) 1226 F ≥70 FFQ
ASVD (fatal ischemic heart disease, heart
failure, cerebrovascular disease excluding
hemorrhage, or peripheral heart disease)
15 No association Blekkenhorst, 2017 [72]
NHS (USA) 71,141 F 50 ± 7 FFQ CHD (fatal CHD or nonfatal MI) 24 22% ↓ RR (high vs.low intake) Bhupathiraju, 2013 [73]
HPFS (USA) 42,135 M 53 ± 10 FFQ CHD (fatal CHD or nonfatal MI) 22 12% ↓ RR (high vs.low intake) Bhupathiraju, 2013 [73]
EPICOR (Italy) 29,689 F 35–74 FFQ CHD (fatal or nonfatal MI or coronaryrevascularization) 7.85
46% ↓ HR (high vs.
low intake) Bendinelli, 2011 [74]
MORGEN
(The Netherlands) 20,069 M and F 20–65 FFQ CHD (fatal CHD or nonfatal acute MI) 10 No association Oude Griep, 2011 [75]
Linxian NIT (China) 2445 M and F 40–69 FFQ Heart disease (death) 26 No association Wang, 2016 [76]
SMC and COSM
(Sweden) 74,961 M and F 45–83 FFQ
Stroke (cerebral infarction, hemorrhagic
stroke or unspecified stroke) 10.2 No association Larsson, 2013 [77]
Linxian NIT (China) 2445 M and F 40–69 FFQ Stroke (death) 26 38% ↓ HR (pertwice/week) Wang, 2016 [76]
NHS and HPFS (USA) 114,279 M and F 34–59 FFQ Ischemic stroke (embolic or thrombotic) 14 84% ↓ RR (high vs.low intake) Joshipura, 1999 [78]
DDCHS (Denmark) 54,506 M and F 50–64 FFQ
Ischemic stroke (ischemic infarction,
intracerebral hemorrhage or
subarachnoid hemorrhage)
3.09 No association Johnsen, 2003 [79]
ASVD, atherosclerotic vascular disease; CHD, coronary heart disease; COSM, Cohort of Swedish Men; CVD, cardiovascular disease; DDCHS, Danish Diet, Cancer, and Healthy Study;
EPICOR, European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts in northern (Turin and Varese), central (Florence), and southern (Naples and Ragusa) Italy; F,
female; FFQ, food frequency questionnaire; HPFS, Health Professionals Follow-up Study; HR, hazard ratio; JPHCPS, Japan Public Health Centre-based Prospective Study; M, male;
MHCPS, Massachusetts Health Care Panel Study; MI, myocardial infarction; MORGEN, Monitoring Project on Risk Factors and Chronic Diseases in The Netherlands; NHS, Nurses’ Health
Study; NIT, Nutrition Intervention Trials; PLSAW, Perth Longitudinal Study of Ageing Women; PREDIMED, PREvención con DIeta MEDiterránea study; ref, reference; RR, relative risk;
SMC, Swedish Mammography Cohort.
Nutrients 2018, 10, 595 7 of 24
The US cohorts, Nurses’ Health Study (NHS) and Health Professionals Follow-up Study (HPFS),
are the largest cohorts demonstrating an inverse association between intakes of leafy green vegetables
and risk of CVD [68], CHD [73] and ischemic stroke [78]. The NHS consists of ~121,700 female
registered nurses aged 30–55 years and the NPFS consists of ~51,529 male health professionals aged
40–75 years. Combining these two large cohorts, Hung et al. [68] reported an adjusted RR of 0.89
(95%CI 0.83–0.96) for CVD for every one serving increment of leafy green vegetables. Combining
the same cohorts, Bhupathiraju et al. [73] reported an adjusted RR of 0.83 (95%CI 0.77–0.91) for CHD
for the highest (median: ~1.5 servings/day) compared with the lowest (median: ~0.2 servings/day)
intakes of leafy green vegetables. For ischemic stroke, Joshipura et al. [78] reported an adjusted RR
of 0.76 (95%CI 0.58–0.99) for the highest (median: 1.36 servings/day) versus the lowest (median:
0.16 servings/day) intakes. However, the translation of these findings into practice are limited, as the
number of grams in one serving was not reported. In a smaller US cohort (n = 1273), the Massachusetts
Health Care Panel Study (MHCPS), Gaziano et al. [71] reported a RR of 0.49 (95%CI 0.31–0.77) for
CVD mortality for those consuming one or more servings per day of salads and leafy green vegetables
compared to those consuming less than one serving per day. Again, the number of grams in one
serving was not reported, making translation difficult. Importantly, only age and sex were used in
the adjusted model, and dietary and lifestyle factors were not taken into consideration. Using the
EPICOR study (the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts in
northern (Turin and Varese), central (Florence), and southern (Naples and Ragusa Italy), Bendinelli
et al. [74] reported an adjusted hazard ratio (HR) of 0.54 (95%CI 0.33–0.90) for CHD for the highest
(>50.8 g/day) compared to the lowest (<17.6 g/day) intakes of leafy green vegetables. This study
consisted of 29,689 females aged 35–74 years. Lastly, using the Linxian Nutrition Intervention Trials
(NIT) cohort in China, Wang et al. [76] reported an adjusted HR of 0.62 (95%CI 0.43–0.91) for stroke
mortality for every twice/week increase in leafy green vegetables. However, this relationship was not
observed for heart disease mortality.
5.2. Cruciferous Vegetables
At least 26 studies have reported the associations between intake of cruciferous vegetables and
CVD [68–71,80–82], ASVD [72], CHD [73–76,81,83], ischemic heart disease (IHD) [72], heart disease [76],
cerebrovascular disease (CVA) [84], ischemic CVA [72], stroke [76,77], ischemic stroke [78,79,84], and
intracerebral hemorrhage [84] (Table 2). Broccoli, Brussels sprouts, cabbage, and cauliflower were the
most common vegetables grouped as cruciferous vegetables. At least eight studies have identified an
inverse relationship between intake of cruciferous vegetables and six separate outcomes: CVD [70,80],
ASVD [72], IHD [72], CVA [84], ischemic stroke [78,84] and intracerebral hemorrhage [84]. Seventeen
studies reporting five outcomes (CVD, CHD, ischemic CVA, ischemic stroke and stroke) have shown
no associations [68,69,71–77,79,81–83].
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Table 2. Prospective cohort studies of cruciferous vegetables and cardiovascular disease outcomes.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
NHS and HPFS (USA) 109,635 M and F 30–75 FFQ CVD (fatal or nonfatal MI or stroke) 12–15 No association Hung, 2004 [68]
JPHCPS (Japan) 77,891 M and F 45–74 FFQ CVD (fatal or nonfatal MI or stroke) 5–8 No association Takachi, 2007 [69]
SWHS (China) 74,942 F 40–70 FFQ CVD (death) 10.2 20% ↓ HR (high vs.low intake) Zhang, 2011 [80]
SMHS (China) 61,500 M 40–74 FFQ CVD (death) 4.6 27% ↓ HR (high vs.low intake) Zhang, 2011 [80]
IWHS (USA) 34,492 F 55–69 FFQ CVD (death) 16 No association Mink, 2007 [81]
PREDIMED (Spain) 7216 M and F 55–80 FFQ CVD (cardiovascular death, MI or stroke) 7 36% ↓ HR (high vs.low intake) Buil-Cosiales, 2016 [70]
Odyssey Cohort (USA) 6151 M and F 30–93 FFQ CVD (death) 14 No association Genkinger, 2004 [82]
MHCPS (USA) 1273 M and F ≥66 FFQ CVD (death) 4.75 No association Gaziano, 1995 [71]
PLSAW (Australia) 1226 F ≥70 FFQ
ASVD (fatal ischemic heart disease, heart
failure, cerebrovascular disease excluding
hemorrhage, or peripheral heart disease)
15 12% ↓ HR (per 10g/day) Blekkenhorst, 2017 [72]
NHS (USA) 71,141 F 50±7 FFQ CHD (fatal CHD or nonfatal MI) 24 No association Bhupathiraju, 2013 [73]
SWHS (China) 67,211 F 40–70 FFQ CHD (fatal CHD or nonfatal MI) 9.8 No association Yu, 2013 [83]
SMHS (China) 55,474 M 40–75 FFQ CHD (fatal CHD or nonfatal MI) 5.4 No association Yu, 2013 [83]
HPFS (USA) 42,135 M 53 ± 10 FFQ CHD (fatal CHD or nonfatal MI) 22 No association Bhupathiraju, 2013 [73]
IWHS (USA) 34,492 F 55–69 FFQ CHD (death) 16 No association Mink, 2007 [81]
EPICOR (Italy) 29,689 F 35–74 FFQ CHD (fatal or nonfatal MI or coronaryrevascularization) 7.85 No association Bendinelli, 2011 [74]
MORGEN
(The Netherlands) 20,069 M and F 20–65 FFQ CHD (fatal CHD or nonfatal acute MI) 10 No association Oude Griep, 2011 [75]
PLSAW (Australia) 1226 F ≥70 FFQ IHD (death) 15 17% ↓ HR (per 10g/day) Blekkenhorst, 2017 [72]
Linxian NIT (China) 2445 M and F 40–69 FFQ Heart disease (death) 26 No association Wang, 2016 [76]
FMCHES (Finland) 3932 M and F 40–74 FFQ CVA (fatal or nonfatal) 24 21% ↓ RR (high vs.low intake) Mizrahi, 2009 [84]
PLSAW (Australia) 1226 F ≥70 FFQ Ischemic CVA (death) 15 No association Blekkenhorst, 2017 [72]
SMC and COSM
(Sweden) 74,961 M and F 45–83 FFQ
Stroke (cerebral infarction, hemorrhagic
stroke or unspecified stroke) 10.2 No association Larsson, 2013 [77]
Linxian NIT (China) 2445 M and F 40–69 FFQ Stroke (death) 26 No association Wang, 2016 [76]
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Table 2. Cont.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
NHS and HPFS (USA) 114,279 M and F 34–59 FFQ Ischemic stroke (embolic or thrombotic) 14 29% ↓ RR (high vs.low intake) Joshipura, 1999 [78]
DDCHS (Denmark) 54,506 M and F 50–64 FFQ
Ischemic stroke (ischemic infarction,
intracerebral hemorrhage or subarachnoid
hemorrhage)
3.09 No association Johnsen, 2003 [79]
FMCHES (Finland) 3932 M and F 40–74 FFQ Ischemic stroke (fatal or nonfatal) 24 33% ↓ RR (high vs.low intake) Mizrahi, 2009 [84]
FMCHES (Finland) 3932 M and F 40–74 FFQ Intracerebral hemorrhage (fatal or nonfatal) 24 51% ↓ RR (high vs.low intake) Mizrahi, 2009 [84]
ASVD, atherosclerotic vascular disease; CHD, coronary heart disease; COSM, Cohort of Swedish Men; CVA, cerebrovascular disease; CVD, cardiovascular disease; DDCHS, Danish Diet,
Cancer, and Healthy Study; EPICOR, European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts in northern (Turin and Varese), central (Florence), and southern (Naples
and Ragusa) Italy; F, female; FFQ, food frequency questionnaire; FMCHES, Finnish Mobile Clinic Health Examination Survey; HPFS, Health Professionals Follow-up Study; HR, hazard
ratio; IHD, ischemic heart disease; IWHS, Iowa Women’s Health Study; JPHCPS, Japan Public Health Centre-based Prospective Study; M, male; MHCPS, Massachusetts Health Care Panel
Study; MI, myocardial infarction; MORGEN, Monitoring Project on Risk Factors and Chronic Diseases in The Netherlands; NHS, Nurses’ Health Study; NIT, Nutrition Intervention Trials;
PLSAW, Perth Longitudinal Study of Ageing Women; PREDIMED, PREvención con DIeta MEDiterránea study; ref, reference; RR, relative risk; SMC, Swedish Mammography Cohort;
SMHS, Shanghai Men’s Health Study; SWHS, Shanghai Women’s Health Study.
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In the Shanghai Women’s Health Study (SWHS), Zhang et al. [80] reported an adjusted HR of
0.80 (95%CI 0.72–0.89) for CVD for the highest intake (median: 166 g/day) of cruciferous vegetables in
comparison to the lowest intake (median: 28 g/day). The SWHS cohort included 74,942 females aged
40–70 years. Similar results were observed in the Shanghai Men’s Health Study (SMHS). An adjusted
HR of 0.78 (95%CI 0.71–0.85) was reported for CVD in 61,500 males aged 40–74 years consuming
the highest intake (median: 208 g/day) of cruciferous vegetables in comparison to the lowest intake
(median: 34 g/day) [80]. No relationship was observed with intake of cruciferous vegetables and
CHD in the same cohorts (SWHS and SMHS) [83]. In the PREvención con DIeta MEDiterránea
(PREDIMED) study, Buil-Cosiales et al. [70] reported an adjusted HR of 0.64 (95%CI 0.42–0.97) for CVD
for the highest cumulative average intake (median: 30 g/day) of cruciferous vegetables in comparison
to the lowest cumulative average intake (median: 3.1 g/day). In an Australian cohort, the Perth
Longitudinal Study of Ageing Women (PLSAW), we have reported an adjusted HR of 0.88 (95%CI
0.81–0.95) for atherosclerotic vascular disease (ASVD) for every 10 g/day increase in cruciferous
vegetables [72]. A similar relationship was evident for IHD (adjusted HR = 0.83, 95%CI 0.75–0.92), but
not for ischemic CVA (adjusted HR = 0.94, 95%CI 0.84–1.05) [72]. In the Finnish Mobile Clinic Health
Examination Survey (FMCHES) cohort (n = 3939), Mizrahi et al. [84] reported an adjusted RR of 0.79
(95%CI 0.63–0.99), 0.67 (95%CI 0.49–0.92), and 0.49 (95%CI 0.25, 0.98) for CVA, ischemic stroke, and
intracerebral hemorrhage, respectively. These results were for the highest intakes (men: 14–269 g/day;
women: 16–188 g/day) compared to the lowest intakes (men: 0–1 g/day; women: 16–188 g/day)
of cruciferous vegetables. In the NHS and NPFS cohorts, highest (median: 1.0 serving/day) versus
lowest (median: 0.14 serving/day) intakes of cruciferous vegetables was associated with a lower RR of
ischemic stroke (adjusted RR = 0.71, 95%CI 0.55–0.93) [78]. However, a similar relationship was not
shown for CVD [68] or CHD [73].
5.3. Allium Vegetables
At least 14 studies have investigated the relationships between intake of allium vegetables and
ASVD [72], CHD [75,83,85,86], IHD [72,87], CVA [88], ischemic CVA [72], stroke [77], acute stroke [88],
ischemic stroke [79], intracerebral hemorrhage [88] and thrombosis or embolia [88] (Table 3). The
majority of these studies have investigated the intake of onions. Four studies have reported inverse
relationships between intake of allium vegetables and ASVD [72], CHD [86], IHD [72] and ischemic
CVA [72] with all other studies reporting no associations [75,77,79,83,85,87,88].
In the PLSAW cohort [72], we have reported an adjusted HR of 0.85 (95%CI 0.75–0.97) for ASVD
for every 5 g/day increase in allium vegetable intake. This relationship remained for IHD (adjusted
HR = 0.82, 95%CI 0.70–0.97) and ischemic CVA (adjusted HR = 0.75, 95%CI 0.60–0.93). In the Finnish
Social Insurance Institution (FSII) cohort, Knekt et al. [86] reported an adjusted RR of 0.50 (95%CI
0.30–0.82) for CHD for women (n = 2385) consuming ≥5 g/day compared with <5 g/day of onions.
This relationship was not observed in men (n = 2748).
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Table 3. Prospective cohort studies of allium vegetables and cardiovascular disease outcomes.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
PLSAW (Australia) 1226 F ≥70 FFQ
ASVD (fatal ischemic heart disease, heart
failure, cerebrovascular disease excluding
hemorrhage, or peripheral heart disease)
15 15% ↓ HR (per 5g/day) Blekkenhorst, 2017 [72]
SWHS (China) 67,211 F 40–70 FFQ CHD (fatal CHD or nonfatal MI) 9.8 No association Yu, 2013 [83]
NHS (USA) 66,360 F 30–55 FFQ CHD (fatal CHD or nonfatal MI) 12 No association Lin, 2007 [85]
SMHS (China) 55,474 M 40–75 FFQ CHD (fatal CHD or nonfatal MI) 5.4 No association Yu, 2013 [83]
MORGEN
(The Netherlands) 20,069 M and F 20–65 FFQ CHD (fatal CHD or nonfatal acute MI) 10 No association Oude Griep, 2011 [75]
FSII (Finland) 2748 M 30–69 DHQ CHD (death) 26 No association Knekt, 1996 [86]
FSII (Finland) 2385 F 30–69 DHQ CHD (death) 26 50% ↓ RR (high vs.low intake) Knekt, 1996 [86]
Caerphilly Study (UK) 2512 M 45–59 FFQ IHD (IHD death, nonfatal MI, MI define byelectrocardiogram) 10 No association Hertog, 1997 [87]
PLSAW (Australia) 1226 F ≥70 FFQ IHD (death) 15 18% ↓ HR (per 5g/day) Blekkenhorst, 2017 [72]
FMCHES (Finland) 9208 M and F ≥15 DHQ CVA (fatal or nonfatal) 28 No association Knekt, 2000 [88]
PLSAW (Australia) 1226 F ≥70 FFQ Ischemic CVA (death) 15 25% ↓ HR (per 5g/day) Blekkenhorst, 2017 [72]
SMC and COSM
(Sweden) 74,961 M and F 45–83 FFQ
Stroke (cerebral infarction, hemorrhagic
stroke or unspecified stroke) 10.2 No association Larsson, 2013 [77]
FMCHES (Finland) 9208 M and F ≥15 DHQ Acute strokes 28 No association Knekt, 2000 [88]
DDCHS (Denmark) 54,506 M and F 50–64 FFQ
Ischemic stroke (ischemic infarction,
intracerebral hemorrhage or subarachnoid
hemorrhage)
3.09 No association Johnsen, 2003 [79]
FMCHES (Finland) 9208 M and F ≥15 DHQ Intracerebral hemorrhage 28 No association Knekt, 2000 [88]
FMCHES (Finland) 9208 M and F ≥15 DHQ Thrombosis or embolia 28 No association Knekt, 2000 [88]
ASVD, atherosclerotic vascular disease; CHD, coronary heart disease; COSM, Cohort of Swedish Men; CVA, cerebrovascular disease; DDCHS, Danish Diet, Cancer, and Healthy Study;
DHQ, dietary history questionnaire; F, female; FFQ, food frequency questionnaire; FMCHES, Finnish Mobile Clinic Health Examination Survey; FSII, Finnish Social Insurance Institution;
HR, hazard ratio; IHD, ischemic heart disease; M, male; MI, myocardial infarction; MORGEN, Monitoring Project on Risk Factors and Chronic Diseases in The Netherlands; NHS, Nurses’
Health Study; PLSAW, Perth Longitudinal Study of Ageing Women; ref, reference; RR, relative risk; SMC, Swedish Mammography Cohort; SMHS, Shanghai Men’s Health Study; SWHS,
Shanghai Women’s Health Study.
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5.4. Yellow-Orange-Red Vegetables
At least 14 studies have reported associations between yellow-orange-red vegetables and
CVD [69,71,81,89,90], ASVD [72], CHD [74,75,85,89], heart disease [76] and stroke [76,77,89] (Table 4).
Tomato, carrot, sweet potato and pumpkin were the major vegetables studied. Five studies have
reported inverse associations between intake of yellow-orange-red vegetables and CVD [71,89,90],
CHD [89] and heart disease [76]. Other studies have reported no associations [69,72,74–77,81,85,89].
In the Framingham Offspring Study, Jacques et al. [89] reported an inverse relationship for
consumption of tomato products (tomatoes, tomato juice and tomato sauce) with an adjusted HR of
0.94 (95%CI 0.88–0.99) for CVD and 0.90 (95%CI 0.83–0.99) for CHD for every one serve increase per
day. This relationship was not observed for stroke. In the MHCPS study, Gaziano et al. [71] reported
an inverse relationship between consumption of carrots and/or squash and CVD mortality. The RR for
those who ate one or more servings per day of carrots and squash was 0.40 (95%CI 0.16–0.98), although
the number of grams in one serving was not reported. Furthermore, this relationship was not observed
for consumption of tomatoes. In the Zutphen Elderly Study, Buijsse et al. [90] reported an inverse
relationship between consumption of carrots and CVD mortality (per SD, RR = 0.83, 95%CI 0.68–1.00).
Lastly, in the Linxian NIT study, Wang et al. [76] reported consumption of yellow-orange vegetables,
such as sweet potatoes, carrots and pumpkins, was inversely associated with heart disease, but not
stroke. The adjusted HR for heart disease was 0.77 (95%CI 0.60–0.97) for every once/day increase in
consumption of yellow-orange vegetables.
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Table 4. Prospective cohort studies of yellow-orange-red vegetables and cardiovascular disease outcomes.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
JPHCPS (Japan) 77,891 M and F 45–74 FFQ CVD (MI or stroke) 5–8 No association Takachi, 2007 [69]
IWHS (USA) 34,489 F 55–69 FFQ CVD (CHD or stroke) 16 No association Mink, 2007 [81]
Framingham Offspring
Study (USA) 2525 M and F 26–79 FFQ
CVD (fatal or nonfatal CHD, CVA,
congestive heart failure or peripheral
vascular disease)
11 6% ↓ HR (per 1serving/day) Jacques, 2013 [89]
MHCPS (USA) 1273 M and F ≥66 FFQ CVD (death) 4.75 60% ↓ RR (≥1 vs. <1serving) Gaziano, 1995 [71]
Zutphen Elderly Study
(The Netherlands) 559 M 65–84 DHQ
CVD (fatal ischemic heart disease, stroke or
other diseases of the circulatory system) 15 17% ↓ RR (per SD) Buijsse, 2008 [90]
PLSAW (Australia) 1226 F ≥70 FFQ
ASVD (fatal ischemic heart disease, heart
failure, cerebrovascular disease excluding
hemorrhage, or peripheral heart disease)
15 No association Blekkenhorst, 2017 [72]
NHS (USA) 66,360 F 30–55 FFQ CHD (fatal CHD or nonfatal MI) 12 No association Lin, 2007 [85]
EPICOR (Italy) 29,689 F 35–74 FFQ CHD (fatal or nonfatal MI orcoronary revascularization) 7.85 No association Bendinelli, 2011 [74]
MORGEN (The
Netherlands) 20,069 M and F 20–65 FFQ CHD (nonfatal acute MI or fatal CHD) 10 No association Oude Griep, 2011 [75]
Framingham Offspring
Study (USA) 2525 M and F 26–79 FFQ
CHD (MI, angina pectoris, coronary
insufficiency or CHD death) 11
10% ↓ HR (per 1
serving/day) Jacques, 2013 [89]
Linxian NIT (China) 2445 M and F 40–69 FFQ Heart disease (death) 26 23% ↓ HR (peronce/day) Wang, 2016 [76]
SMC and COSM
(Sweden) 74,961 M and F 45–83 FFQ
Stroke (cerebral infarction, hemorrhagic
stroke or unspecified stroke) 10.2 No association Larsson, 2013 [77]
Framingham Offspring
Study (USA) 2525 M and F 26–79 FFQ Stroke (nonfatal) 11 No association Jacques, 2013 [89]
Linxian NIT (China) 2445 M and F 40–69 FFQ Stroke (death) 26 No association Wang, 2016 [76]
ASVD, atherosclerotic vascular disease; CHD, coronary heart disease; CVD, cardiovascular disease; DHS, dietary history questionnaire; EPICOR, European Prospective Investigation
into Cancer and Nutrition (EPIC) cohorts in northern (Turin and Varese), central (Florence), and southern (Naples and Ragusa) Italy; F, female; FFQ, food frequency questionnaire;
HR, hazard ratio; IWHS, Iowa Women’s Health Study; JPHCPS, Japan Public Health Centre-based Prospective Study; M, male; MHCPS, Massachusetts Health Care Panel Study; MI,
myocardial infarction; MORGEN, Monitoring Project on Risk Factors and Chronic Diseases in The Netherlands; NHS, Nurses’ Health Study; NIT, Nutrition Intervention Trials; PLSAW,
Perth Longitudinal Study of Ageing Women; ref, reference; RR, relative risk.
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5.5. Legumes
At least 28 studies have reported on the relationships between legume consumption
and CVD [68,91–94], ischemic CVD [95], ASVD [72], CHD [76,83,91–93,96–100], CVA [84,101],
stroke [76,91,102,103], ischemic stroke [78,84] and intracerebral hemorrhage [84] (Table 5). At least
seven studies have reported inverse associations between intakes of legumes and CVD [91,93,94],
ischemic CVD [95], CHD [93], heart disease [76], and ischemic stroke [84]. However, some studies
have demonstrated no relationship [68,72,76,78,83,84,91,92,96–103].
In the Japanese Collaborative Cohort Study (JCCS), Nagura et al. [91] reported an inverse
relationship between bean intake and CVD with an adjusted HR of 0.84 (95%CI 0.74–0.95) for
those consuming the highest (median: 4.5 servings/week) compared to the lowest (median:
0.8 servings/week) bean intake. This relationship was not evident for CHD and stroke. In the
First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study (NHEFS),
Bazzano et al. [93] reported an adjusted RR of 0.89 (95%CI 0.80–0.98) for CVD and 0.78 (95%CI
0.68–0.90) for CHD for those who consumed legumes ≥4 times per week compared to those who
consumed legumes less than once per week. In the Isfahan Cohort Study (ICS) in Iran, Nouri et al. [94]
reported a 33% lower risk of CVD for old-aged individuals consuming high intakes (>3 times per week)
compared to low intakes (0–1 time per week) of legumes (HR = 0.66, 95%CI 0.45–0.98). In the Japan
Public Health Centre-Based (JPHC) Study, Kokubo et al. [95] reported an inverse relationship between
soy intake and ischemic CVD mortality. The adjusted HR was 0.31 (95%CI 0.13–0.74) for women
consuming high intakes (≥5 days per week) compared to low intakes (0–2 days per week) of soy. This
relationship was primarily observed in postmenopausal women and was not observed in men or for
dietary intakes of beans. Wang et al. [76] reported an inverse relationship between bean intake and
heart disease with an adjusted HR of 0.63 (95%CI 0.48–0.83) for increasing bean intake four times/week.
This relationship was not observed for stroke. In the FMCHES study, Mizrahi et al. [84] reported an
inverse relationship between consumption of legumes and ischemic stroke with an adjusted RR of 0.72
(95%CI 0.54–0.96) for those consuming the highest intakes (men: 10–101 g/day; women: 7–43 g/day)
compared to the lowest intakes (men: 0–2 g/day; women: 0–1 g/day). Other related outcomes
including CVA and intracerebral hemorrhage were not related.
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Table 5. Prospective cohort studies of legumes and cardiovascular disease outcomes.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
NHS and HPFS (USA) 109,635 M and F 30–75 FFQ CVD (fatal or nonfatal MI or stroke) 12–15 No association Hung, 2004 [68]
JCCS (Japan) 59,485 M and F 40–79 FFQ CVD (death) 12.7 16% ↓ HR (high vs.low intake) Nagura, 2009 [91]
The SUN Project
(Spain) 13,609 M and F 38 FFQ
CVD (cardiovascular death, MI,
revascularization procedures, fatal or
nonfatal stroke)
4.9 No association Martínez-González,2011 [92]
NHEFS (USA) 9632 M and F 25–74 FFQ CVD (fatal or nonfatal) 21 11% ↓ RR (≥4 vs.<1 times/week) Bazzano, 2001 [93]
ICS (Iran) 6504 M and F ≥35 FFQ CVD (fatal or nonfatal MI, sudden cardiacdeath, unstable angina or stroke) 6.8
33% ↓ HR (>55 years
only) (high vs. low
intake)
Nouri, 2016 [94]
JPHC (Japan) 40,462 M and F 40–59 FFQ Ischemic CVD (fatal CI or MI) 13 69% ↓ HR (F only)(high vs. low intake) Kokubo, 2007 [95]
PLSAW (Australia) 1226 F ≥70 FFQ
ASVD (fatal ischemic heart disease, heart
failure, cerebrovascular disease excluding
hemorrhage, or peripheral heart disease
15 No association Blekkenhorst, 2017 [72]
IWHS (USA) 99,826 F 55–69 FFQ CHD (death) 15 No association Kelemen, 2005 [96]
NHS (USA) 84,136 F 30–55 FFQ CHD (fatal CHD or nonfatal MI) 26 No association Bernstein, 2010 [97]
SWHS (China) 67,211 F 40–70 FFQ CHD (fatal CHD or nonfatal MI) 9.8 No association Yu, 2013 [83]
JCCS (Japan) 59,485 M and F 40–79 FFQ CHD (death) 12.7 No association Nagura, 2009 [91]
SMHS (China) 55,474 M 40–75 FFQ CHD (fatal CHD or nonfatal MI) 5.4 No association Yu, 2013 [83]
EPIC (Spain) 41,078 M and F 29–69 FFQ CHD (fatal or nonfatal) 10.4 No association Buckland, 2009 [98]
EPIC (Greece) 23,929 M and F 20–86 FFQ CHD (fatal or nonfatal MI, angina or otherCHD) 10 No association Dilis, 2012 [99]
The SUN Project
(Spain) 13,609 M and F 38 FFQ CHD (fatal) 4.9 No association
Martínez-González,
2011 [92]
ARIC (USA) 12,066 M and F 45–64 FFQ CHD (fatal CHD or nonfatal MI) 22 No association Haring, 2014 [100]
NHEFS (USA) 9632 M and F 25–74 FFQ CHD (fatal or nonfatal) 21 22% ↓ RR (≥4 vs.<1 time/week) Bazzano, 2001 [93]
Linxian NIT (China) 2445 M and F 40–69 FFQ Heart disease (death) 26 37% ↓ HR(4 times/week) Wang, 2016 [76]
EPIC (Greece) 23,601 M and F 25–67 FFQ CVA (fatal or nonfatal) 10.6 No association Misirli, 2012 [101]
FMCHES (Finland) 3932 M and F 40–74 FFQ CVA (fatal or nonfatal) 24 No association Mizrahi, 2009 [84]
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Table 5. Cont.
Study Cohort
(Country)
Sample
Number Sex Age (years)
Dietary Assessment
Method Outcome
Follow-up
(years) Results First Author, Year (ref)
NHS (USA) 84,010 F 30–55 FFQ Stroke (fatal or nonfatal ischemic,hemorrhagic or other stroke) 26 No association Bernstein, 2012 [102]
JCCS (Japan) 59,485 M and F 40–79 FFQ Stroke (fatal ischemic orhemorrhagic stroke) 12.7 No association Nagura, 2009 [91]
HPFS (USA) 43,150 M 40–75 FFQ Stroke (fatal or nonfatal ischemic,hemorrhagic or other stroke) 22 No association Bernstein, 2012 [102]
ARIC (USA) 11,601 M and F 45–64 FFQ Stroke (fatal or nonfatal ischemic orhemorrhagic stroke) 22.7 No association Haring, 2015 [103]
Linxian NIT (China) 2445 M and F 40–69 FFQ Stroke (death) 26 No association Wang, 2016 [76]
NHS and HPFS (USA) 114,279 M and F 34–59 FFQ Ischemic stroke (embolic or thrombotic) 14 No association Joshipura, 1999 [78]
FMCHES (Finland) 3932 M and F 40–74 FFQ Ischemic stroke (fatal or nonfatal) 24 28% ↓ RR (high vs.low intake) Mizrahi, 2009 [84]
FMCHES (Finland) 3932 M and F 40–74 FFQ Intracerebral hemorrhage (fatal or nonfatal) 24 No association Mizrahi, 2009 [84]
ARIC, Atherosclerosis Risk in Communities; ASVD, atherosclerotic vascular disease; CHD, coronary heart disease; CI, cerebral infarction; CVA, cerebrovascular disease; CVD, cardiovascular
disease; EPIC, European Prospective Investigation into Cancer and Nutrition; F, female; FFQ, food frequency questionnaire; FMCHES, Finnish Mobile Clinic Health Examination Survey;
HPFS, Health Professionals Follow-up Study; HR, hazard ratio; ICS, Isfahan Cohort Study; IWHS, Iowa Women’s Health Study; JCCS, Japanese Collaborative Cohort Study; JPHC, Japan
Public Health Centre-Based Study; M, male; MI, myocardial infarction; NHEFS, First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study; NHS, Nurses’
Health Study; NIT, Nutrition Intervention Trials; PLSAW, Perth Longitudinal Study of Ageing Women; ref, reference; SMHS, Shanghai Men’s Health Study; SUN, Seguimiento Universidad
de Navarra; SWHS, Shanghai Women’s Health Study.
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6. Limitations and Future Directions
Although nutrition epidemiology has been successful in providing insight into the potential
causes and prevention of many health conditions, several important limitations still exist [104]. Due
to the observational nature of nutrition epidemiological studies, residual confounding is inevitable.
Challenges also arise in the accuracy of assessing dietary intake [104]. These factors can lead to
contradictory findings, especially when comparing results across different populations where dietary
assessment methods are sometimes weak and there is large heterogeneity amongst the populations
studied. Relationships between vegetable intake and CVD outcomes may be attenuated when
large differences in vegetable intake classification and/or categorization exist. There is a need for
the international standardization of such variables to limit error, thereby enabling more accurate
comparisons between investigations. Such changes if implemented in large cohort studies have the
capacity to improve the quality of nutrition research. Technology-based dietary assessment methods
in conjunction with recovery biomarkers, such as those that appear in plasma or urine, could be used
to improve accuracy and are worth considering in future work [105]. Finally, adopting STROBE-nut
guidelines and checklists will improve reporting of nutritional epidemiological studies and the quality
of published literature [105,106].
Most prospective studies reported in this review were undertaken in older populations. Greater
statistical power is present in studies with more events, which occur more frequently in older
populations. Therefore, these populations are frequently selected to study disease-related outcomes
such as CVD. It is clear that dietary changes later in life can significantly reduce the risk of chronic
disease within five years [107,108]. However, it is likely that the greatest cardiovascular benefit would
be to increase vegetable intake throughout the life course. Future studies are needed to evaluate the
relationships between intake of specific vegetables and cardiometabolic health outcomes in younger
populations. Due to the small number of events that would occur in younger populations, markers of
cardiometabolic health are an alternative to study. It is also not known whether the health benefits of
increasing vegetable intake is associated with particular racial or ethnic populations, and therefore this
should be addressed in future research.
7. Conclusions
Many large observational follow-up studies have reported the inverse associations of leafy green,
cruciferous, allium, yellow-orange-red vegetables, and legumes with CVD outcomes. These vegetables
contain many nutrients and phytochemicals that have been postulated to have cardiovascular health
benefits. Some studies demonstrate no associations between specific vegetable types and CVD
outcomes. This may be due to type II error and/or bias introduced by measurement error and
regression dilution, attenuating observed risk estimates [12]. Other inherit limitations of observational
epidemiological studies may also influence relationships. This presents a major limitation of nutritional
epidemiology, making the interpretation and comparison of results difficult [109].
The evidence in this review suggests intake of leafy green and cruciferous vegetables may
confer strong cardiovascular health benefits. Increasing vegetable intake, with a focus on consuming
leafy green and cruciferous vegetables may provide the greatest cardiovascular health benefits.
Incorporating such dietary changes along with other recommended lifestyle changes will optimize
health benefits. Lifestyle changes include consuming a diet full of vegetable, fruits, and whole grains;
including low-fat dairy products, poultry, fish, legumes, non-tropical vegetable oils, and nuts; and
limiting intake of saturated and trans fats, sweets, sugar-sweetened beverages, and red meats [110].
Other lifestyle changes include increasing physical activity [110], avoiding cigarette smoking [110]
and intake of alcohol [111], and maintaining a healthy body weight by consuming appropriate energy
requirements [110]. There is a need for very large well-designed epidemiological studies investigating
the cardiovascular health benefits of different vegetable types. Large long-term randomized controlled
trials are needed to establish the causal effects of the specific vegetables found to be most beneficial for
cardiovascular health.
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